EdgeNewswire

Yamaha Motor Launches Strategic Partnership with Nikon Instruments, USA - Creating Synergies Between Both Companies in Advanced Technologies and Support Services for Drug Discovery -

  • 2 min read
  • Yamaha Motor Co., Ltd.

At a glance

Company
Yamaha Motor Co., Ltd.
Ticker
Tokyo: 7272
Announcement
Partnership
Location
Iwata, Shizuoka, Japan

Products and programs

  • CELL HANDLER 2

Iwata, Shizuoka, Japan, December 5, 2025 -- Yamaha Motor Co., Ltd. (Tokyo: 7272) announced today that the company has entered into a strategic partnership with Nikon Instruments Inc. (Head Office: New York, USA; regarding the initiatives of both companies in drug discovery and research processes. Through this partnership, the Nikon BioImaging Lab (NBIL) located in Boston Massachusetts, USA, will serve as a showroom for Yamaha Motor's innovative cell picking and imaging system, CELL HANDLER 2. By integrating NBIL's advanced imaging technologies with the capabilities of CELL HANDLER 2, the collaboration will provide dedicated support for U.S.-based researchers engaged in drug discovery and related research.

Based on this collaboration, Yamaha Motor has installed its CELL HANDLER 2 at NBIL, the R&D hub operated by Nikon Instruments. This will give researchers in the United States access to Yamaha Motor's state-of-the-art cell picking and imaging system in the same facility as Nikon's cutting edge imaging technologies.
In addition, as part of NBIL's support services for drug discovery and research, researchers considering the purchase of CELL HANDLER 2 will be able to conduct verification tests using their own samples to confirm the system's effectiveness in cell picking. This will allow the development of assay workflows tailored to each customer's specific research needs.
Through this collaboration, the aim is to expand the use of both Nikon Instruments' imaging technologies and Yamaha Motor's CELL HANDLER 2, system for streamlined research and experimental workflows involving cells.

Nikon Instruments is a wholly owned U.S. subsidiary of Nikon Corporation (Head Office: Shinagawa-ku, Tokyo), engaged in the development and manufacture of optical and digital imaging technologies for biomedical applications. The company established NBIL in 2019 to provide research support specializing in microscope imaging and image analysis.

Yamaha Motor launched CELL HANDLER 2, a cell picking and imaging system designed to enhance the efficiency and refinement of research and experiments for new drug development, in March 2025. Having identified strong synergies with Nikon Instruments, which also offers products and services for cellular research, we reached this agreement.



CELL HANDLER 2


Nikon BioImaging Lab, USA

If you detect any issues, problems, or errors in this press release content, kindly contact [email protected] to notify us (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). We will respond and rectify the situation in the next 8 hours.

In brief

Yamaha Motor says it has formed a strategic partnership with Nikon Instruments to support U.S.-based researchers working in drug discovery and related research. Under the arrangement, Yamaha Motor has installed its CELL HANDLER 2 cell-picking and imaging system at Nikon BioImaging Lab (NBIL), Nikon Instruments’ research facility in Boston. Researchers considering the system can use their own samples for verification tests and assess its cell-picking performance, with the aim of developing assay workflows suited to their research needs. The companies intend to combine NBIL’s imaging capabilities with CELL HANDLER 2 and make the system available in the same facility as Nikon’s imaging technologies. Yamaha Motor launched CELL HANDLER 2 in March 2025, according to the release.

Key takeaways

  • Yamaha Motor installed CELL HANDLER 2 at Nikon BioImaging Lab in Boston.
  • Researchers considering the system can conduct verification tests using their own samples.
  • The partnership is intended to support U.S. drug discovery and related research.
  • The companies aim to develop assay workflows tailored to researchers’ needs.

Earlier from Yamaha Motor Co., Ltd.

  1. Yamaha Motor Launches New Variations in Its Robonity Series - Three New Types Added: Long-Stroke, Timing Belt Drive, and Low-Profile, Bringing the Lineup to 54 Models
  2. Yamaha Motor Launches Two New Electric Scooter Models for India - Initiatives aimed at achieving environmental targets through models developed in-house and with River Mobility -
  3. Yamaha Motor to Propose Next-Generation Transport Solutions at iREX2025 - Combining Two Kinds of "Transportation" to Create Efficient Smart Factories -
  4. Yamaha Motor to Reveal YE-01 Electric Motocross Concept Model at EICMA 2025 - Seeking to compete in the new MXEP electric motocross racing series -
  5. Yamaha Motor Co., Ltd. Consolidated Business Results Summary - First Nine Months of Fiscal Year Ending December 31, 2025
Back to News Center
EdgeNewswire

EdgeNewswire distributes your news to a targeted and established network of journalists and media outlets. We help build visibility and credibility for your organization and brand through trusted media coverage.

Copyright © 2024 - 2026   EdgeNewswire – Cutting Edge Press Release Distribution Services. All Rights Reserved.